Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 30 Records) |
Query Trace: CYP2A13[original query] |
---|
Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method. Toxicology 2001 Nov 168 (3): 259-68. Paschke T, Riefler M, Schuler-Metz A, Wolz L, Scherer G, McBride C M, Bepler |
Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. The Journal of pharmacology and experimental therapeutics 2002 Aug 302 (2): 416-23. Zhang Xiuling, Su Ting, Zhang Qing-Yu, Gu Jun, Caggana Michele, Li Hongming, Ding Xinx |
Single nucleotide polymorphisms of the human cyp2a13 gene: evidence for a null allele. Drug metabolism and disposition: the biological fate of chemicals 2003 Sep 31 (9): 1081-5. Zhang Xiuling, Chen Ying, Liu Yiqin, Ren Xiang, Zhang Qing-Yu, Caggana Michele, Ding Xinx |
Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer research 2003 Nov 63 (22): 8057-61. Wang Haijian, Tan Wen, Hao Bingtao, Miao Xiaoping, Zhou Gangqiao, He Fuchu, Lin Dongx |
Genetic polymorphisms of CYP2A13 and its relationship to nasopharyngeal carcinoma in the Cantonese population. Journal of translational medicine 2004 Jun 2 (1): 24. Jiang Ju-Hong, Jia Wei-Hua, Chen Han-Kui, Feng Bing-Jian, Qin Hai-De, Pan Zhi-Gang, Shen Guo-Ping, Huang Li-Xi, Feng Qi-Sheng, Chen Li-Zhen, Lin Dong-Xin, Zeng Yi-X |
Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. Biochemical and biophysical research communications 2004 Apr 317 (2): 662-9. Cauffiez C, Lo-Guidice JM, Quaranta S, Allorge D, Chevalier D, Cenée S, Hamdan R, Lhermitte M, Lafitte JJ, Libersa C, Colombel JF, Stücker I, Broly F |
Arg257Cys polymorphism of CYP2A13 in a Chinese population. Clinica chimica acta; international journal of clinical chemistry 2004 May 343 (1-2): 213-6. Cheng Xin-Yuan, Chen Guo-Lin, Zhang Wei-Xia, Zhou Gan, Wang Dan, Zhou Hong-H |
CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations. Xenobiotica; the fate of foreign compounds in biological systems 2005 Jul 35 (7): 661-9. Cauffiez C, Pottier N, Tournel G, Lo-Guidice J-M, Allorge D, Chevalier D, Migot-Nabias F, Kenani A, Broly |
CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences. Carcinogenesis 2009 Jul 30 (7): 1161-9. Timofeeva Maria N, Kropp Silke, Sauter Wiebke, Beckmann Lars, Rosenberger Albert, Illig Thomas, Jäger Birgit, Mittelstrass Kirstin, Dienemann Hendrik, , Bartsch Helmut, Bickeböller Heike, Chang-Claude Jenny C, Risch Angela, Wichmann Heinz-Eri |
Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer detection and prevention 2009 Mar . Song DK, Xing DL, Zhang LR, Li ZX, Liu J, Qiao BP |
CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk. Pancreas 2010 Mar 39 (2): 144-8. Mohelnikova-Duchonova Beatrice, Vrana David, Holcatova Ivana, Ryska Miroslav, Smerhovsky Zdenek, Soucek Pav |
Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer. Oral diseases 2010 Oct 16 (7): 668-73. Sharma R, Panda N K, Khullar |
Polymorphisms in metabolizing enzymes and the risk of head and neck squamous cell carcinoma in the Slavic population of the central Europe. Neoplasma 2010 57 (5): 415-21. Soucek P, Susova S, Mohelnikova-Duchonova B, Gromadzinska J, Moraviec-Sztandera A, Vodicka P, Vodickova |
Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians. Oral diseases 2010 Nov 16 (8): 760-8. Sharma R, Ahuja M, Panda Nk, Khullar |
Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan. Drug metabolism and pharmacokinetics 2011 26 (5): 516-22. Tamaki Yuichiro, Arai Tomio, Sugimura Haruhiko, Sasaki Takamitsu, Honda Masashi, Muroi Yuka, Matsubara Yoichi, Kanno Shuichi, Ishikawa Masaaki, Hirasawa Noriyasu, Hiratsuka Masahi |
Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals. Drug metabolism and pharmacokinetics 2011 26 (5): 544-7. Tamaki Yuichiro, Honda Masashi, Muroi Yuka, Arai Tomio, Sugimura Haruhiko, Matsubara Yoichi, Kanno Shuichi, Ishikawa Masaaki, Hirasawa Noriyasu, Hiratsuka Masahi |
Interactions among genetic variants in tobacco metabolizing genes and smoking are associated with head and neck cancer susceptibility in North Indians. DNA and cell biology 2011 Aug 30 (8): 611-6. Sharma Rajni, Ahuja Monica, Panda Naresh K, Khullar Mad |
'Smoking genes': a genetic association study. PloS one 2011 6 (10): e26668. Verde Zoraida, Santiago Catalina, Rodríguez González-Moro José Miguel, de Lucas Ramos Pilar, López Martín Soledad, Bandrés Fernando, Lucia Alejandro, Gómez-Gallego Fél |
An investigation of the catalytic activity of CYP2A13*4 with coumarin and polymorphisms of CYP2A13 in a Chinese Han population. Drug metabolism and disposition: the biological fate of chemicals 2012 Feb . Liu T, Hong Y, Li Z, Hong J, Zeng S, Zheng M, Chen S |
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma. Toxicology letters 2013 Jan 216 (1): 16-22. Chung Chi-Jung, Pu Yeong-Shiau, Shiue Horng-Sheng, Lee Hui-Ling, Lin Pinpin, Yang Hsiu-Yuan, Su Chien-Tien, Hsueh Yu-M |
Pulmonary CYP2A13 levels are associated with early occurrence of lung cancer-Its implication in mutagenesis of non-small cell lung carcinoma. Cancer epidemiology 2013 Oct 37 (5): 5. Chiang HC, Lee H, Chao HR, Chiou YH, Tsou TC |
Genotyping of wild-type cytochrome P450 2A6 and whole-gene deletion using human blood samples and a multiplex real-time polymerase chain reaction method with dual-labeled probes. Clinica chimica acta; international journal of clinical chemistry 2015 Feb 441 71-4. Shimizu Makiko, Sawaya Ren, Kishimoto Izumi, Yamazaki Hiros |
Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genetic interaction is associated with lung cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2015 May 29 (5): 1986-98. Xiang Chan, Wang Jiucun, Kou Xiaochen, Chen Xiabin, Qin Zhaoyu, Jiang Yan, Sun Chang, Xu Jibin, Tan Wen, Jin Li, Lin Dongxin, He Fuchu, Wang Haiji |
Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers. Current drug metabolism 2015 16 (10): 850-63. He Xin, Feng Sh |
CYP2A13 Genetic Polymorphisms in Relation to the Risk of Bladder Cancer in Japanese Smokers. Biological & pharmaceutical bulletin 2016 39 (10): 1683-1686. Kumondai Masaki, Hosono Hiroki, Orikasa Kazuhiko, Arai Yoichi, Arai Tomio, Sugimura Haruhiko, Ozono Seiichiro, Sugiyama Takayuki, Takayama Tatsuya, Sasaki Takamitsu, Hirasawa Noriyasu, Hiratsuka Masahi |
HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers. Thoracic cancer 2019 Feb . Hua Feng, Guo Yonglu, Sun Qiang, Yang Leizhou, Gao Fa |
Association between CYP2A13 polymorphisms and lung cancer: A protocol for systematic review and meta-analysis. Medicine 2020 Dec 99 (50): e23289. Ma Long, Jin Gang, Yang Yi, Pang Yao, Wang Wenhao, Zhang Hongyi, Liu Jiawei, Wu Peng, Wang Zequan, Wang Kui, Chang Ruitong, Li Jialong, Zhu Zijia |
Independent and Interactive Effect of CYPs and GSTs Genetic Variants and Tobacco Smoking on the Risk of Non-Small Cell Lung Carcinoma. Archives of medical research 2021 Jun . Pathak Anumesh K, Husain Nuzhat, Kant Surya, Bala Laksh |
The Role of Pharmacogenetics in Smoking. Clinical pharmacology and therapeutics 2021 6 110 (3): 599-606. El-Boraie Ahmed, Tyndale Rachel |
Whole-Genome Sequencing Analysis Reveals New Susceptibility Loci and Structural Variants Associated with Progressive Supranuclear Palsy. medRxiv : the preprint server for health sciences 2024 1 . Hui Wang, Timothy S Chang, Beth A Dombroski, Po-Liang Cheng, Vishakha Patil, Leopoldo Valiente-Banuet, Kurt Farrell, Catriona Mclean, Laura Molina-Porcel, Alex Rajput, Peter Paul De Deyn, Nathalie Le Bastard, Marla Gearing, Laura Donker Kaat, John C Van Swieten, Elise Dopper, Bernardino F Ghetti, Kathy L Newell, Claire Troakes, Justo G de Yébenes, Alberto Rábano-Gutierrez, Tina Meller, Wolfgang H Oertel, Gesine Respondek, Thomas Arzberger, Sigrun Roeber, Pau Pastor, Alexis Brice, Alexandra Durr, Isabelle Le Ber, Thomas G Beach, Geidy E Serrano, Lili-Naz Hazrati, Irene Litvan, Rosa Rademakers, Owen A Ross, Douglas Galasko, Adam L Boxer, Bruce L Miller, Willian W Seeley, Vivanna M Van Deerlin, Charles L White, Huw Morris, Rohan de Silva, John F Crary, Alison M Goate, Jeffrey S Friedman, Yuk Yee Leung, Giovanni Coppola, Adam C Naj, Li-San Wang, Dennis W Dickson, Günter U Höglinger, Gerard D Schellenberg, Daniel H Geschwind, Wan-Ping L |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: